Ricardo D Parrondo Selected Research

Ricardo D Parrondo Research Topics

13	Multiple Myeloma 01/2024 - 01/2020
4	Neoplasms (Cancer) 01/2023 - 01/2020
2	Immunoglobulin Light-chain Amyloidosis 10/2023 - 12/2020
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022 - 10/2020
2	Residual Neoplasm 01/2022 - 01/2020
1	Cytokine Release Syndrome 10/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Exanthema (Rash) 10/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Plasma Cell Leukemia 01/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Bone Diseases (Bone Disease) 01/2019

4	Lenalidomide (CC 5013)FDA Link 01/2023 - 01/2021
3	Proteasome InhibitorsIBA 01/2021 - 01/2020
2	Bispecific AntibodiesIBA 01/2024 - 12/2020
2	idecabtagene vicleucelIBA 10/2023 - 01/2022
2	Chimeric Antigen ReceptorsIBA 10/2023 - 12/2020
2	AntibodiesIBA 10/2023 - 12/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 10/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2022
2	ibrutinibIBA 10/2022 - 01/2022
2	Immunomodulating AgentsIBA 12/2020 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 01/2019
1	PENTAIBA 01/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2023
1	B-Cell Maturation AntigenIBA 10/2023
1	gossypol acetic acidIBA 01/2023
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	RNA Splicing FactorsIBA 01/2023
1	venetoclaxIBA 07/2022
1	ixazomibIBA 03/2021
1	daratumumabIBA 01/2021
1	Melphalan (Alkeran)FDA LinkGeneric 12/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 12/2020
1	Immunoconjugates (Immunoconjugate)IBA 12/2020
1	Immunoglobulin M (IgM)IBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	APOBEC-1 DeaminaseIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Denosumab FDA Link 01/2019
1	CytokinesIBA 01/2019
1	LigandsIBA 01/2019

8	Therapeutics 01/2024 - 01/2020
5	Cell Transplantation 10/2023 - 10/2020
2	Immunotherapy 10/2023 - 12/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
2	Autologous Transplantation 01/2022 - 01/2021
1	Transplantation 01/2021
1	Salvage Therapy 01/2020
1	Stem Cell Transplantation 01/2020